Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

10.1245/s10434-008-9928-8
Annals of Surgical Oncology 15:2020-2026 (2008)
© 2008 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Son, Y.-I.
Right arrow Articles by Choi, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Son, Y.-I.
Right arrow Articles by Choi, J.

Original Article

Extent of Prophylactic Lymph Node Dissection in the Central Neck Area of the Patients with Papillary Thyroid Carcinoma: Comparison of Limited Versus Comprehensive Lymph Node Dissection in a 2-Year Safety Study

Young-Ik Son, MD, PhD1, Han-Sin Jeong, MD, PhD1, Chung-Hwan Baek, MD, PhD1, Man Ki Chung, MD1, Junsun Ryu, MD, PhD2, Jae Hoon Chung, MD, PhD3, Yoon Kyung So, MD1, Jeon Yeob Jang, MD1 and Jeesun Choi, MD1

1 Department of Otorhinolaryngology—Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 Head and Neck Oncology Clinic, Center for Special Organs, National Cancer Center, Ilsan, Korea
3 Department of Endocrinology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Correspondence: Address correspondence and reprint requests to: Han-Sin Jeong, MD, PhD; E-mail: hansjeong{at}skku.edu

Background: To compare the "comprehensive" (including bilateral paratracheal, pretracheal, prelaryngeal lymph nodes) (CCND) with "limited" (saving contralateral paratracheal lymph nodes) central node dissection (LCND) for postoperative complications and disease recurrence rate in sonographically node-negative papillary thyroid carcinomas.

Materials and Methods: From 2003 to 2005, 114 consecutive patients, diagnosed as sonographically node-negative thyroid papillary carcinomas, were included retrospectively. Among them, the LCND was performed in 56 patients and CCND in 58 patients, in combination with total thyroidectomy, based on the operator-dependent decision. We compared the complication rates and the recurrence rates between these two groups with a mean follow-up duration of 2 years.

Results: Transient hypocalcemia was more frequent in the CCND group than in the LCND group (48.3% vs 26.8%, P = .02, odds ratio [OR] = 2.55). However, the other complication rates were similar in the two groups. In addition, the immediate postoperative reduction of parathyroid hormone (PTH) was more evident in the CCND group. The postoperative PTH levels increased up to a similar level (12.4 vs 11.8 pg/mL) over 6 months. The incidence of permanent hypocalcemia did not differ significantly between the two groups. Four (7.1%) and five recurrences (8.6%) were found in two groups, respectively, implying similar oncological safety during the 2-year follow-up.

Conclusion: The LCND with total thyroidectomy could be an alternative treatment option for node-negative papillary thyroid carcinomas, because LCND had fewer short-term hypocalcemia and similar oncological outcomes during the 2-year follow-up. Further study enrolling a large number of patients with long-term follow-up is needed.

Key Words: Thyroid carcinomas • Papillary carcinomas • Lymph node dissection • Lymph node metastasis




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
A. Toniato
Prophylactic Lymph Node Dissection in Papillary Thyroid Carcinoma
Ann. Surg. Oncol., November 1, 2008; 15(11): 3322 - 3323.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
H.-S. Jeong
Prophylactic Lymph Node Dissection in Papillary Thyroid Carcinoma
Ann. Surg. Oncol., November 1, 2008; 15(11): 3324 - 3325.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society of Surgical Oncology.